livehealth.store

Takeda Development Center Americas recalls

Takeda Development Center Americas has 2 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 21 Nov 2018. The most frequent reason is potency & assay.

Total recalls2since 2018

Last 12 months0reported

Class I00% of total

Ongoing0latest 21 Nov 2018

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 1 50%Class III 1 50%

Why takeda development center americas is recalled

Potency & Assay150%
Other Reasons150%

Product types

Diabetes Medication150%

By year

20182100%

All takeda development center americas recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
21 Nov 2018Drug	CLASS III	Amitiza (lubiprostone) capsules 8 mcg recalledAmitiza	Takeda Development Center Americas	Potency & Assay	Nationwide
17 Oct 2018Drug	CLASS II	Actoplus met XR (pioglitazone and metformin HCl recalled	Takeda Development Center Americas	Other	9 states

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.